SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
7.14
+0.52 (7.85%)
At close: Nov 6, 2026, 4:00 PM EST
7.28
+0.14 (1.96%)
After-hours: Nov 6, 2026, 7:38 PM EST

SOPHiA GENETICS Revenue

SOPHiA GENETICS had revenue of $24.27M in the quarter ending September 30, 2026, with 24.69% growth. This brings the company's total for the last twelve months to $90.97M, up 24.11% year-over-year. In the year 2025, SOPHiA GENETICS had annual revenue of $77.27M with 18.56% growth. That makes SOPHiA GENETICS the 23,402nd largest company in the world by revenue and 3,358th in the United States.

Revenue (ttm)
$90.97M
Revenue Growth
+24.11%
P/S Ratio
6.72
Revenue / Employee
$219,210
Employees
415
Market Cap
611.60M

Revenue Chart

Revenue by Geography

  • Rest of Europe, The Middle East, and Africa (EMEA) 25.65M 33.2%
  • France 11.32M 14.6%
  • United States 10.87M 14.1%
  • Italy 10.81M 14.0%
  • Spain 6.03M 7.8%
  • Asia-Pacific (APAC) 5.21M 6.7%
  • Latin America (LATAM) 3.09M 4.0%
  • Other 4.30M 5.6%
Fiscal year ended Dec 31, 2025 See the full SOPHiA GENETICS breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202577.27M12.10M18.56%
Dec 31, 202465.17M2.80M4.49%
Dec 31, 202362.37M14.81M31.14%
Dec 31, 202247.56M7.11M17.58%
Dec 31, 202140.45M12.05M42.43%
Dec 31, 202028.40M3.04M11.98%
Dec 31, 201925.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Teladoc Health2.47B
Evolent Health2.34B
Omnicell1.24B
Claritev994.67M
GoodRx Holdings785.23M
Phreesia507.79M
Omada Health333.04M
HealthStream327.95M
Revenue Rankings